The clinical association of the blood pressure variability with the target organ damage in hypertensive patients with chronic kidney disease

Journal of Korean Medical Science

Volumn 29, Issue 7, 2014, Pages 957-964

  Ryu, Jiwon ^a   Cha, Ran hui ^b   Kim, Dong Ki ^h   Lee, Ju Hyun ^a   Yoon, Sun Ae ^c   Ryu, Dong Ryeol ^d   Oh, Ji Eun ^e   Kim, Sejoong ^a   Han, Sang Youb ^f   Lee, Eun Young ^g   Kim, Yon Su ^h  

^a Seoul National University Bundang Hospital   (South Korea)

^b National Medical Center   (South Korea)

^c The Catholic University of Korea College of Medicine   (South Korea)

^d Ewha Womans University School of Medicine   (South Korea)

^e Hallym University College of Medicine   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Soonchunhyang University College of Medicine   (South Korea)

^h Seoul National University College of Medicine   (South Korea)

Author keywords

Blood pressure variability; Hypertension; Hypertrophy, left ventricular; Kidney failure, chronic; Target organ damage

Indexed keywords

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPLICATION; CROSS-SECTIONAL STUDY; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INJURIES; KIDNEY; MALE; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC; RISK;

ADULT; AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; MALE; MIDDLE AGED; ODDS RATIO; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84925231216     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2014.29.7.957     Document Type: Article

References (37)

1. Rothwell PM. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-48.
2. Okada H, Fukui M, Tanaka M, Inada S, Mineoka Y, Nakanishi N, Sen-maru T, Sakabe K, Ushigome E, Asano M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220: 155-9.
3. Poortvliet RK, Ford I, Lloyd SM, Sattar N, Mooijaart SP, de Craen AJ, Westendorp RG, Jukema JW, Packard CJ, Gussekloo J, et al. Blood pres-sure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One 2012; 7: e52438.
4. Mena L, Pintos S, Queipo NV, Aizpúrua JA, Maestre G, Sulbarán T. A re-liable index for the prognostic significance of blood pressure variability. J Hypertens 2005; 23: 505-11.
5. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57: 160-6.
6. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
7. McMullan CJ, Bakris GL, Phillips RA, Forman JP. Association of BP vari-ability with mortality among African Americans with CKD. Clin J Am Soc Nephrol 2013; 8: 731-8.
8. Di Iorio B, Pota A, Sirico ML, Torraca S, Di Micco L, Rubino R, Guasta-ferro P, Bellasi A. Blood pressure variability and outcomes in chronic kidney disease. Nephrol Dial Transplant 2012; 27: 4404-10.
9. Pringle E, Phillips C, Thijs L, Davidson C, Staessen JA, de Leeuw PW, Jaaskivi M, Nachev C, Parati G, O'Brien ET, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21: 2251-7.
10. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K. Visit-to-visit and ambulatory blood pressure variability as predictors of incident car-diovascular events in patients with hypertension. Am J Hypertens 2012; 25: 962-8.
11. Schillaci G, Bilo G, Pucci G, Laurent S, Macquin-Mavier I, Boutouyrie P, Battista F, Settimi L, Desamericq G, Dolbeau G, et al. Relationship be-tween short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012; 60: 369-77.
12. Diaz KM, Veerabhadrappa P, Kashem MA, Thakkar SR, Feairheller DL, Sturgeon KM, Ling C, Williamson ST, Kretzschmar J, Lee H, et al. Visit-to-visit and 24-h blood pressure variability: association with endothelial and smooth muscle function in African Americans. J Hum Hypertens 2013; 27: 671-7.
13. Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun Oh J, Han SY, Young Lee E, Ki Kim D, Kim YS. Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: re-sults of the APrODiTe study. Hypertens Res 2014; 37: 172-78.
14. Lee CS, Cha RH, Lim YH, Kim H, Song KH, Gu N, Yu KS, Lim CS, Han JS, Kim S, et al. Ethnic coefficients for glomerular filtration rate estima-tion by the Modification of Diet in Renal Disease Study equations in the Korean population. J Korean Med Sci 2010; 25: 1616-25.
15. Romhilt DW, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968; 75: 752-8.
16. Fagard R, Brguljan J, Thijs L, Staessen J. Prediction of the actual awake and asleep blood pressures by various methods of 24 h pressure analysis. J Hypertens 1996; 14: 557-63.
17. Park SM, Ro YM, Ahn JC, Lim DS, Park CG, Kim YH, Seo HS, Shim WJ, Oh DJ. An appraisal of the electrocardiographic criteria for diagnosis of left ventricular hypertrophy in Koreans: comparison to echocardiograph-ic measurement of left ventricular mass. Korean Circ J 2004; 34: 775-83.
18. Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measure-ments on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem 2005; 51: 1577-86.
19. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Chris-tiaens T, Cifkova R, De Backer G, Dominiczak A, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-219.
20. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Tot-sune K, Hoshi H, Satoh H, Imai Y. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pres-sure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508-15.
21. Diaz KM, Veerabhadrappa P, Kashem MA, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL, Brown MD. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in Afri-can Americans. Hypertens Res 2012; 35: 55-61.
22. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93-8.
23. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, et al. Prognostic val-ue of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 2010; 55: 1049-57.
24. Tatasciore A, Zimarino M, Renda G, Zurro M, Soccio M, Prontera C, Emdin M, Flacco M, Schillaci G, DE Caterina R. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension. Hypertens Res 2008; 31: 2137-46.
25. Abramson JL, Lewis C, Murrah NV, Anderson GT, Vaccarino V. Relation of C-reactive protein and tumor necrosis factor-alpha to ambulatory blood pressure variability in healthy adults. Am J Cardiol 2006; 98: 649-52.
26. Kim KI, Lee JH, Chang HJ, Cho YS, Youn TJ, Chung WY, Chae IH, Choi DJ, Park KU, Kim CH. Association between blood pressure variability and inflammatory marker in hypertensive patients. Circ J 2008; 72: 293-8.
27. Veerabhadrappa P, Diaz KM, Feairheller DL, Sturgeon KM, Williamson S, Crabbe DL, Kashem A, Ahrensfield D, Brown MD. Enhanced blood pressure variability in a high cardiovascular risk group of African Amer-icans: FIT4Life Study. J Am Soc Hypertens 2010; 4: 187-95.
28. Kawai T, Ohishi M, Ito N, Onishi M, Takeya Y, Yamamoto K, Kamide K, Rakugi H. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardio-vascular disease. J Hypertens 2013; 31: 1387-95.
29. Devereux RB, Casale PN, Eisenberg RR, Miller DH, Kligfield P. Electro-cardiographic detection of left ventricular hypertrophy using echocar-diographic determination of left ventricular mass as the reference stan-dard: comparison of standard criteria, computer diagnosis and physi-cian interpretation. J Am Coll Cardiol 1984; 3: 82-7.
30. Hameed W, Razi MS, Khan MA, Hussain MM, Aziz S, Habib S, Aslam M. Electrocardiographic diagnosis of left ventricular hypertrophy: compari-son with echocardiography. Pak J Physiol 2005; 1: 35-8.
31. Jain A, Tandri H, Dalal D, Chahal H, Soliman EZ, Prineas RJ, Folsom AR, Lima JA, Bluemke DA. Diagnostic and prognostic utility of electro-cardiography for left ventricular hypertrophy defined by magnetic reso-nance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2010; 159: 652-8.
32. Miao CY, Xie HH, Zhan LS, Su DF. Blood pressure variability is more im-portant than blood pressure level in determination of end-organ dam-age in rats. J Hypertens 2006; 24: 1125-35.
33. Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P. Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabe-tes. Diabet Med 2012; 29: 990-4.
34. Kawai T, Ohishi M, Kamide K, Nakama C, Onishi M, Ito N, Takami Y, Takeya Y, Rakugi H. Differences between daytime and nighttime blood pressure variability regarding systemic atherosclerotic change and renal function. Hypertens Res 2013; 36: 232-9.
35. KDIGO. KDIGO 2012 clinical practice guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150.
36. Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of associa-tions of urine protein-creatinine ratio versus albumin-creatinine ratio with complications of CKD: a cross-sectional analysis. Am J Kidney Dis 2013; 62: 1102-8.
37. Atkins RC, Briganti EM, Zimmet PZ, Chadban SJ. Association between albuminuria and proteinuria in the general population: the AusDiab Study. Nephrol Dial Transplant 2003; 18: 2170-4.